135 related articles for article (PubMed ID: 8859012)
1. Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4.
Ma Y; Hurst HE; Fernandez-Botran R
J Pharmacol Exp Ther; 1996 Oct; 279(1):340-50. PubMed ID: 8859012
[TBL] [Abstract][Full Text] [Related]
2. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset.
Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE
Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705
[TBL] [Abstract][Full Text] [Related]
3. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo.
Sato TA; Widmer MB; Finkelman FD; Madani H; Jacobs CA; Grabstein KH; Maliszewski CR
J Immunol; 1993 Apr; 150(7):2717-23. PubMed ID: 8454851
[TBL] [Abstract][Full Text] [Related]
4. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor.
Blum H; Wolf M; Enssle K; Röllinghoff M; Gessner A
J Immunol; 1996 Sep; 157(5):1846-53. PubMed ID: 8757301
[TBL] [Abstract][Full Text] [Related]
5. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4.
Chilton PM; Fernandez-Botran R
J Immunol; 1993 Dec; 151(11):5907-17. PubMed ID: 8245438
[TBL] [Abstract][Full Text] [Related]
6. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor.
Fanslow WC; Clifford KN; Park LS; Rubin AS; Voice RF; Beckmann MP; Widmer MB
J Immunol; 1991 Jul; 147(2):535-40. PubMed ID: 1830065
[TBL] [Abstract][Full Text] [Related]
7. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis.
Fernandez-Botran R; Wynn TA; Hieny S; Caspar P; Chilton PM; Sher A
Eur J Immunol; 1995 Mar; 25(3):649-56. PubMed ID: 7705393
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
König B; Fischer A; König W
Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the expression of the soluble and membrane forms of the murine IL-4 receptor.
Chilton PM; Fernandez-Botran R
Cell Immunol; 1997 Sep; 180(2):104-15. PubMed ID: 9341740
[TBL] [Abstract][Full Text] [Related]
10. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.
Maliszewski CR; Sato TA; Vanden Bos T; Waugh S; Dower SK; Slack J; Beckmann MP; Grabstein KH
J Immunol; 1990 Apr; 144(8):3028-33. PubMed ID: 2139075
[TBL] [Abstract][Full Text] [Related]
11. A soluble form of IL-13 receptor alpha 1 promotes IgG2a and IgG2b production by murine germinal center B cells.
Poudrier J; Graber P; Herren S; Gretener D; Elson G; Berney C; Gauchat JF; Kosco-Vilbois MH
J Immunol; 1999 Aug; 163(3):1153-61. PubMed ID: 10415009
[TBL] [Abstract][Full Text] [Related]
12. Human interleukin 4 receptor complex: neutralization effect of two monoclonal antibodies.
Taremi SS; Prosise WW; Rajan N; O'Donnell RA; Le HV
Biochemistry; 1996 Feb; 35(7):2322-31. PubMed ID: 8652573
[TBL] [Abstract][Full Text] [Related]
13. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.
Sang DK; Ouma JH; John CC; Whalen CC; King CL; Mahmoud AA; Heinzel FP
J Infect Dis; 1999 Mar; 179(3):743-6. PubMed ID: 9952391
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic parameters and biodistribution of soluble cytokine receptors.
Jacobs CA; Beckmann MP; Mohler K; Maliszewski CR; Fanslow WC; Lynch DH
Int Rev Exp Pathol; 1993; 34 Pt B():123-35. PubMed ID: 8384610
[TBL] [Abstract][Full Text] [Related]
16. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression, and purification of soluble human interleukin-4 receptor in Streptomyces.
Zhang Y; Wang WC; Li Y
Protein Expr Purif; 2004 Jul; 36(1):139-45. PubMed ID: 15177295
[TBL] [Abstract][Full Text] [Related]
18. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes.
Finkelman FD; Madden KB; Morris SC; Holmes JM; Boiani N; Katona IM; Maliszewski CR
J Immunol; 1993 Aug; 151(3):1235-44. PubMed ID: 8393043
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice.
Kobayashi H; Kobayashi M; Utsunomiya T; Herndon DN; Pollard RB; Suzuki F
J Immunol; 1999 Jun; 162(12):7148-54. PubMed ID: 10358160
[TBL] [Abstract][Full Text] [Related]
20. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
Chabaud M; Miossec P
Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
